Tumor-associated trypsin inhibitor

被引：0
|
作者：
Stenman, UH [1 ]
机构：
[1] Univ Helsinki, Cent Hosp, Dept Clin Chem, Biomedicum, FIN-00029 Helsinki, Finland
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Tumor-associated trypsin inhibitor (TATI) is a low-molecular-weight (6 kDa) trypsin inhibitor that has been used as a marker for ovarian cancer. It is also expressed together with tumor-associated trypsin by many other tumors, and increased serum concentrations of TATI occur in connection with these. TATI is a prognostic marker for ovarian, bladder, and kidney cancer, which may be associated with the participation of trypsin in protease cascades contributing to tumor invasiveness. (C) 2002 American Association for Clinical Chemistry.
引用
收藏
页码：1206 / 1209
页数：4
相关论文
共 50 条
  • [31] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) AS A MARKER OF OVARIAN-CANCER
    FISKEN, J
    LEONARD, RCF
    ROULSTON, JE
    BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 823 - 823
  • [32] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN PRIMARY ESOPHAGEAL-CARCINOMA
    GION, M
    MIONE, R
    TREMOLADA, C
    DALLAPALMA, P
    RUOL, A
    DITTADI, R
    LEON, A
    NOSADINI, A
    CASTORO, C
    BRUSCAGNIN, G
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 37 - 41
  • [33] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR AS A POSSIBLE MARKER IN MALE-INFERTILITY
    BANFI, G
    MURONE, M
    VIGANO, P
    BRIGANTE, C
    BONINI, PA
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 51 - 53
  • [34] TATI (TUMOR-ASSOCIATED TRYPSIN-INHIBITOR) AS TUMOR-MARKER IN OVARIAN-CANCER
    MEDL, M
    OGRIS, E
    LOEDOLTER, S
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 931 - 933
  • [35] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN SERUM AS TUMOR-MARKER IN GYNECOLOGY AND UROLOGY
    CRASS, G
    WAGNER, W
    GLAUBITT, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 315 - 315
  • [36] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN SERUM AS TUMOR-MARKER - EVALUATION IN GYNECOLOGY
    CRASS, G
    GLAUBITT, D
    MARX, M
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 293 - 293
  • [37] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) AS A POSSIBLE MARKER OF MALE-INFERTILITY
    BANFI, G
    BRIGANTE, C
    MURONE, M
    SGUOTTI, C
    BONINI, PA
    VIGNALI, M
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 285 - 285
  • [38] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR, TATI, IN GASTROINTESTINAL CANCER AND RELATED BENIGN DISEASES
    PIANTINO, P
    AROASIO, E
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 67 - 69
  • [39] SERUM LEVELS OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN BENIGN AND MALIGNANT GYNECOLOGICAL DISEASES
    TORRE, GC
    REMBADO, R
    BARBETTI, V
    VIGLIERCIO, GP
    FOGLIA, M
    CALABRESE, A
    CORONGIU, F
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 15 - 18
  • [40] EVALUATION OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN WOMEN WITH BENIGN AND MALIGNANT GYNECOLOGICAL DISEASE
    INAUDI, P
    PETRILLI, S
    DELEO, V
    BERNABEI, A
    PASQUI, L
    DANTONA, N
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 11 - 13
12345